HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lenore C Ocava Selected Research

LXR 1035

11/2006EDG receptors as a potential therapeutic target in retinal ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lenore C Ocava Research Topics

Disease

2Stroke (Strokes)
05/2008 - 02/2006
2Ischemic Stroke
05/2008 - 02/2006
2Embolic Stroke
05/2008 - 02/2006
1Ischemia
11/2006
1Reperfusion Injury
11/2006

Drug/Important Bio-Agent (IBA)

2Fibrinolytic Agents (Antithrombotic Agents)IBA
05/2008 - 02/2006
1PlasminogenIBA
05/2008
1LXR 1035IBA
11/2006
1Sphingosine-1-Phosphate ReceptorsIBA
11/2006
1Retinaldehyde (Retinal)IBA
11/2006
1Lysophosphatidic Acid ReceptorsIBA
11/2006
1Tissue Plasminogen Activator (Alteplase)FDA Link
02/2006

Therapy/Procedure

2Therapeutics
05/2008 - 02/2006
2Thrombolytic Therapy
05/2008 - 02/2006
2Contraindications
05/2008 - 02/2006
1Intravitreal Injections
11/2006